儿童导管导向神经血管造影期间线粒体应激与DNA损伤生物标志物的前瞻性单中心研究
前瞻性单中心研究纳入27例接受神经血管造影的儿童,检测外周血单核细胞线粒体应激(MMP、ROS、mtDNA)和DNA损伤(γH2AX)标志物。未发现生物标志物与辐射剂量呈剂量依赖性反应;高剂量组MMP和mtDNA显著变化,但低剂量组无显著变化。作者认为线粒体应激标志物值得进一步研究用于辐射生物剂量测定,但需区分辐射特异性效应与操作应激和全身麻醉的影响。
要点
- 儿童神经血管造影后外周血单核细胞线粒体标志物在高剂量组出现显著变化,低剂量组无显著变化。
- γH2AX和ROS未显示与辐射剂量相关的剂量依赖性反应或组间显著差异。
- 作者认为线粒体应激标志物值得进一步研究用于辐射生物剂量测定。
核心结论
- 儿童神经血管造影期间可在外周血单核细胞中检测到线粒体应激生物标志物,值得进一步研究用于辐射生物剂量测定;但将辐射特异性效应与操作应激和全身麻醉的影响区分开需要进一步研究。
研究设计与样本
- 前瞻性单中心研究,纳入27例儿童,在神经血管造影前后采集血液并分离外周血单核细胞,检测线粒体应激标志物(MMP、ROS、mtDNA)和DNA损伤标志物(γH2AX);采用线性回归分析生物标志物与辐射剂量的剂量反应关系,将队列分为高剂量组和低剂量组,使用线性混合模型分析并用Welch t检验比较。
诊断标准与关键数值
- γH2AX与辐射剂量无剂量依赖性反应:R²=0.0012,P=0.86。
- MMP与辐射剂量无剂量依赖性反应:R²=0.016,P=0.53。
- mtDNA与辐射剂量无剂量依赖性反应:R²=0.10,P=0.11。
- ROS与辐射剂量无剂量依赖性反应:R²=0.0023,P=0.81。
- 高剂量组MMP变化-53.7±14.7 AU(P=0.0014),mtDNA变化-1.1±0.4 AU(P=0.0092);低剂量组MMP变化26.1±14.7 AU(P=0.090),mtDNA变化0.2±0.4(P=0.65)。
临床应用与阅片要点
- 儿童神经血管造影中可检测外周血单核细胞线粒体应激标志物,但作者认为其用于辐射生物剂量测定值得进一步研究。
- 作者指出将辐射特异性效应与操作应激和全身麻醉的影响区分开需要进一步研究。
局限性
- 作者指出将辐射特异性效应与操作应激和全身麻醉的影响区分开需要进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Neuroangiography represents a critical diagnostic and therapeutic imaging modality whose associated radiation may be of concern in children. The availability of in vivo radiation damage markers would represent a key advancement for understanding radiation effects and aid in the development of radioprotective strategies.
OBJECTIVE: Determine if biomarkers of cellular damage can be detected in the peripheral blood mononuclear cells (PBMC) of children undergoing neuroangiography.
MATERIALS AND METHODS: Prospective single-site study of 27 children. Blood collected pre and post neuroangiography, from which PBMC were isolated and assayed for biomarkers of mitochondrial stress (mitochondrial membrane potential (MMP), reactive oxygen species (ROS), and mitochondrial DNA (mtDNA)) and DNA damage (γH2AX). Dose response of biomarkers vs. radiation dose was analyzed using linear regressions. The cohort was divided into higher (HD) and lower dose (LD) groups and analyzed using linear mixed models and compared using Welch's t-tests.
RESULTS: No biomarker exhibited a dose-dependent response following radiation (γH2AX: R2 = 0.0012, P = 0.86; MMP: R2 = 0.016, P = 0.53; mtDNA: R2 = 0.10, P = 0.11; ROS: R2 = 0.0023, P = 0.81). Groupwise comparisons showed no significant differences in γH2AX or ROS after radiation (γH2AX: LD: 0.6 ± 6.0, P = 0.92; HD: -7.5 ± 6.3 AU, P = 0.24; ROS: LD: 1.3 ± 2.8, P = 0.64; HD: -3.6 ± 3.0 AU, P = 0.24). Significant changes were observed to mitochondrial markers MMP (-53.7 ± 14.7 AU, P = 0.0014) and mtDNA (-1.1 ± 0.4 AU, P = 0.0092) for HD, but not the LD group (MMP: 26.1 ± 14.7 AU, P = 0.090; mtDNA: 0.2 ± 0.4, P = 0.65).
CONCLUSIONS: Biomarkers of mitochondrial stress in PBMC were identified during pediatric neuroangiography and warrant further investigation for radiation biodosimetry. However, isolating radiation-specific effects from those of procedural stress and general anesthesia requires further investigation.
引用
- Hogarth KA, Shkumat NA, Goman S, et al. Biomarkers of mitochondrial stress and DNA damage during pediatric catheter-directed neuroangiography - a prospective single-center study. Pediatr Radiol. 2024. PMID: 39285018. doi:10.1007/s00247-024-06048-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。